These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Low Protein Expression of both Brondani VB; Lacombe AMF; Mariani BMP; Montenegro L; Soares IC; Bezerra-Neto JE; Tanno FY; Srougi V; Chambo JL; Mendonca BB; Almeida MQ; Zerbini MCN; Fragoso MCBV Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513905 [TBL] [Abstract][Full Text] [Related]
4. Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma. Landwehr LS; Altieri B; Sbiera I; Remde H; Kircher S; Olabe J; Sbiera S; Kroiss M; Fassnacht M J Clin Endocrinol Metab; 2024 Aug; 109(9):2325-2334. PubMed ID: 38415841 [TBL] [Abstract][Full Text] [Related]
5. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients. Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819 [TBL] [Abstract][Full Text] [Related]
6. Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma. Suzuki S; Minamidate T; Shiga A; Ruike Y; Ishiwata K; Naito K; Ishida A; Deguchi H; Fujimoto M; Koide H; Tatsuno I; Ikeda JI; Yamazaki Y; Sasano H; Yokote K BMC Endocr Disord; 2020 Nov; 20(1):173. PubMed ID: 33228607 [TBL] [Abstract][Full Text] [Related]
7. Adrenocortical cancer: mortality, hormone secretion, proliferation and urine steroids - experience from a single centre spanning three decades. Calissendorff J; Calissendorff F; Falhammar H BMC Endocr Disord; 2016 Mar; 16():15. PubMed ID: 26984275 [TBL] [Abstract][Full Text] [Related]
8. Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma. Poli G; Ruggiero C; Cantini G; Canu L; Baroni G; Armignacco R; Jouinot A; Santi R; Ercolino T; Ragazzon B; Assie G; Mannelli M; Nesi G; Lalli E; Luconi M J Clin Endocrinol Metab; 2019 May; 104(5):1712-1724. PubMed ID: 30476173 [TBL] [Abstract][Full Text] [Related]
9. Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications. Sbiera I; Kircher S; Altieri B; Lenz K; Hantel C; Fassnacht M; Sbiera S; Kroiss M Front Endocrinol (Lausanne); 2021; 12():795116. PubMed ID: 34956100 [TBL] [Abstract][Full Text] [Related]
10. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861 [TBL] [Abstract][Full Text] [Related]
11. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089 [TBL] [Abstract][Full Text] [Related]
12. Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival. Waldmann J; Feldmann G; Slater EP; Langer P; Buchholz M; Ramaswamy A; Saeger W; Rothmund M; Fendrich V Br J Cancer; 2008 Dec; 99(11):1900-7. PubMed ID: 19018264 [TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience. Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I BMC Urol; 2015 May; 15():43. PubMed ID: 26013141 [TBL] [Abstract][Full Text] [Related]
16. Feminizing Adrenocortical Carcinoma: The Source of Estrogen Production and the Role of Adrenal-Gonadal Dedifferentiation. Wu L; Xie J; Jiang L; Su T; Ye L; Zhou W; Jiang Y; Zhang C; Ning G; Wang W J Clin Endocrinol Metab; 2018 Oct; 103(10):3706-3713. PubMed ID: 30053001 [TBL] [Abstract][Full Text] [Related]
17. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma. Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908 [TBL] [Abstract][Full Text] [Related]
19. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune-related pathways. Veronez LC; das Chagas PF; Corrêa CAP; Baroni M; da Silva KR; Nagano LF; Borges KS; Queiroz RGP; Tone LG; Scrideli CA J Cell Biochem; 2021 Dec; 122(12):1925-1935. PubMed ID: 34581457 [TBL] [Abstract][Full Text] [Related]